[go: up one dir, main page]

DE69713611D1 - Verwendung von natrium 2-mercaptoethansulfonat in der chirurgie - Google Patents

Verwendung von natrium 2-mercaptoethansulfonat in der chirurgie

Info

Publication number
DE69713611D1
DE69713611D1 DE69713611T DE69713611T DE69713611D1 DE 69713611 D1 DE69713611 D1 DE 69713611D1 DE 69713611 T DE69713611 T DE 69713611T DE 69713611 T DE69713611 T DE 69713611T DE 69713611 D1 DE69713611 D1 DE 69713611D1
Authority
DE
Germany
Prior art keywords
pct
tissues
mercaptoethanesulfonate
sodium
surgery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69713611T
Other languages
English (en)
Other versions
DE69713611T2 (de
Inventor
Carlo Zini
Salvatore Bacciu
Angelo Gandolfi
Fabio Piazza
Enrico Pasanisi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
A R D O ASSOCIAZIONE RICERCA E
Original Assignee
A R D O ASSOCIAZIONE RICERCA E
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A R D O ASSOCIAZIONE RICERCA E filed Critical A R D O ASSOCIAZIONE RICERCA E
Application granted granted Critical
Publication of DE69713611D1 publication Critical patent/DE69713611D1/de
Publication of DE69713611T2 publication Critical patent/DE69713611T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
DE69713611T 1996-10-11 1997-10-07 Verwendung von natrium 2-mercaptoethansulfonat in der chirurgie Expired - Lifetime DE69713611T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT96MI002117A IT1284973B1 (it) 1996-10-11 1996-10-11 Uso del sodio 2-mercaptoetansolfonato (mesna) in chirurgia
PCT/EP1997/005485 WO1998016213A1 (en) 1996-10-11 1997-10-07 Use of sodium 2-mercaptoethanesulfonate in surgery

Publications (2)

Publication Number Publication Date
DE69713611D1 true DE69713611D1 (de) 2002-08-01
DE69713611T2 DE69713611T2 (de) 2003-01-30

Family

ID=11375023

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69713611T Expired - Lifetime DE69713611T2 (de) 1996-10-11 1997-10-07 Verwendung von natrium 2-mercaptoethansulfonat in der chirurgie

Country Status (9)

Country Link
US (1) US6143797A (de)
EP (1) EP0930878B1 (de)
JP (1) JP4208967B2 (de)
AT (1) ATE219668T1 (de)
AU (1) AU4707797A (de)
DE (1) DE69713611T2 (de)
ES (1) ES2178760T3 (de)
IT (1) IT1284973B1 (de)
WO (1) WO1998016213A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20030175A1 (it) * 2003-02-04 2004-08-05 Giorgio Conti Uso del 2-mercaptoetansolfonato di sodio come agente antivirale
CN101072571A (zh) * 2004-12-10 2007-11-14 爱尔康公司 用于治疗耳感染的组合物
CN105899200A (zh) 2013-11-17 2016-08-24 阿迪制药有限公司 用于治疗辐射诱发的胃肠道损伤的方法
WO2021013713A1 (en) 2019-07-19 2021-01-28 Auxin Surgery Sa Mesna composition, kit comprising mesna and method for visualization of a mesna composition applied to tissues
US11906719B2 (en) * 2020-01-24 2024-02-20 Spiral Therapeutics Inc. Devices, systems, and methods for treating ear disorders
BR112023002926A2 (pt) * 2020-08-26 2023-04-25 Cila Therapeutic Inc Agentes terapêuticos inaláveis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5244920A (en) * 1985-04-15 1993-09-14 Schering Spa Pharmaceutical compositions having therapeutical activity based on mercaptoethansulphonic arginine salt
ES2040394T3 (es) * 1988-03-19 1993-10-16 Asta Medica Aktiengesellschaft Procedimiento para preparar un material liofilizado de ifosfamida y mesna.
DE4233842A1 (de) * 1992-10-08 1994-04-14 Asta Medica Ag Mesna Injektionslösungen
US5661188A (en) * 1995-06-07 1997-08-26 Medical Research Foundation and Infrastructure Development for Health Services--Nahariya Hospital Branch Therapeutic uses for sodium 2-mercaptoethanesulphonate (mesna)

Also Published As

Publication number Publication date
US6143797A (en) 2000-11-07
EP0930878A1 (de) 1999-07-28
JP4208967B2 (ja) 2009-01-14
DE69713611T2 (de) 2003-01-30
ITMI962117A1 (it) 1998-04-11
IT1284973B1 (it) 1998-05-28
WO1998016213A1 (en) 1998-04-23
AU4707797A (en) 1998-05-11
JP2001508033A (ja) 2001-06-19
ATE219668T1 (de) 2002-07-15
EP0930878B1 (de) 2002-06-26
ES2178760T3 (es) 2003-01-01

Similar Documents

Publication Publication Date Title
ES2083595T3 (es) Derivados de indol que inhiben la biosintesis de leucotrienos.
ATE300597T1 (de) Behandlung von geweben
DE69929810D1 (de) Verwendung von tetracyclinderivaten zur steigerung der interleukin-10 produktion
DE69921156D1 (de) Verwendung von 5ht-6 antagonisten zur behandlung adhd
DE59611411D1 (de) Verwendung von alpha 1l-agonisten zur behandlung der harninkontinenz
NO970805D0 (no) Anvendelse av smaklös, hydrolysert kollagen og middel inneholdende samme
DE69839696D1 (de) Anellierte dihydropyrane
ATE218350T1 (de) Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen
ATE311853T1 (de) Verwendung von krillenzymen zur behandlung von zahnbelag
BR9913705A (pt) Métodos de tratamento de mieloma múltiplo e reabsorção de tecido ósseo induzido por mieloma utilizando antagonistas de integrin
DE69838509D1 (de) Verwendung von rekombinanten menschlichen uteroglobin zur behandlung von fibrotischen krankheitszuständen
ATE219668T1 (de) Verwendung von natrium 2-mercaptoethansulfonat in der chirurgie
ATE410181T1 (de) Verwendung von intereferon gamma zur behandlung von herzhypertrophie
ATE106736T1 (de) Verwendung von dimethylpolysiloxan zur behandlung von erkrankungen des gastrointestinaltraktes.
DE69931487D1 (de) Verwendung von apomorphin zur behandlung der vorzeitigen ejakulation
ATE223721T1 (de) Edelfosin zur behandlung von hirntumoren
TR200200278T2 (tr) Kalsilitik bileşimler
BR0113147A (pt) Proteìnas e peptìdeos do estresse e métodos de uso dos mesmos
ATE375152T1 (de) Behandlung von gastrointestinalen erkrankungen mit n-2,3,3-tetramethylbicyclo[2.2.1]heptan-2- amine
DE69724944D1 (de) Peptidverbindungen mit mmp- und tnf-hemmender wirkung
ATE278407T1 (de) Verwendung von d-galaktose zur verhinderung von nekrosen
DE69626010D1 (de) Verwendung von tropolon derivate zur hemmung des inositmono phosphatase
DE59813303D1 (de) Disaccharidderivate zur behandlung von hyperglykämien
NO984965L (no) Komponent B som cicatrisant
DE69532959D1 (de) D-ring modifizierte gibberellinverbindungen und ihre herstellung und verwendung